MindWalk Holdings (HYFT) Operating Margin (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Operating Margin of 0.0% for Q2 2026, little changed year-over-year from 0.0% in Q2 2025, and up 99.98% quarter-over-quarter from 0.6% in Q1 2026.
Powered by 
Analysis
MindWalk Holdings (HYFT) Operating Margin (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Operating Margin for 7 consecutive years, with 0.0% the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Margin changed 0.0% year-over-year to 0.0%; the TTM figure through Apr 2026 stood at 0.03% (up 5301.0% YoY), while the FY2026 annual figure was 0.24%, up 8.0% from the prior year.
- Operating Margin advanced to 0.0% in Q2 2026 per HYFT's latest filing, from 0.6% in the prior quarter.
- Across five years, Operating Margin topped out at 399.86% in Q2 2023 and bottomed at 197.09% in Q3 2024.
- Historically, Operating Margin has averaged 6.29% across 5 years, with a median of 0.07% in 2023.
- Annual changes were most pronounced in 2022 — Operating Margin slumped 2000000000 bps — and 2023, when it jumped 48169 bps.
- MindWalk Holdings' Operating Margin stood at 0.0% in 2022, then sank by 30292 bps to 0.05% in 2023, then slumped by 329801 bps to 151.33% in 2024, then jumped by 100 bps to 0.07% in 2025, then soared by 100 bps to 0.0% in 2026.
- Business Quant data shows HYFT's Operating Margin at 0.0% in Q2 2026, 0.6% in Q1 2026, and 0.07% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | 19.75% |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -0.36% |
| 10 | MindWalk Holdings | 61.69 Mn | 53.41 Mn | 1.82 Mn | -105.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -105.20% |
| Jan 31, 2026 | -88.36% |
| Oct 31, 2025 | -67.29% |
| Jul 31, 2025 | -131.57% |
| Apr 30, 2025 | -251.55% |
| Jan 31, 2025 | -911.25% |
| Oct 31, 2024 | -151.33% |
| Jul 31, 2024 | -197.09% |
| Apr 30, 2024 | 287.01% |
| Jan 31, 2024 | -53.69% |
| Oct 31, 2023 | -93,854.41% |
| Jul 31, 2023 | -120,274.35% |
| Apr 30, 2023 | -108.09% |
| Jan 31, 2023 | -88.57% |
| Oct 31, 2022 | -150.93% |
| Jul 31, 2022 | -214.20% |
| Apr 30, 2022 | -81.83% |
| Jan 31, 2022 | -69.16% |
| Oct 31, 2021 | -94.09% |
| Jul 31, 2021 | -75.56% |